FULGENT GENETICS, INC. Income (Loss) from Continuing Operations, Per Basic Share
FULGENT GENETICS, INC. (FLGT) reported Income (Loss) from Continuing Operations, Per Basic Share of -$1.05 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:IncomeLossFromContinuingOperationsPerBasicShare · last filed 2026-07-30
- FULGENT GENETICS, INC. income (loss) from continuing operations, per basic share for the quarter ending 2026-06-30 was -$1.05.
- FULGENT GENETICS, INC. income (loss) from continuing operations, per basic share for the quarter ending 2026-03-31 was -$0.80.
- FULGENT GENETICS, INC. income (loss) from continuing operations, per basic share for the quarter ending 2025-09-30 was -$0.21.
- FULGENT GENETICS, INC. income (loss) from continuing operations, per basic share for the quarter ending 2025-06-30 was -$0.62.
- FULGENT GENETICS, INC. income (loss) from continuing operations, per basic share for fiscal 2025 was -$1.97.
- FULGENT GENETICS, INC. income (loss) from continuing operations, per basic share for fiscal 2024 was -$1.41.
- FULGENT GENETICS, INC. income (loss) from continuing operations, per basic share for fiscal 2023 was -$5.63, a 218.28% decline from fiscal 2022.
- FULGENT GENETICS, INC. income (loss) from continuing operations, per basic share for fiscal 2022 was $4.76, a 72.41% decline from fiscal 2021.
| Period end | Income (Loss) from Continuing Operations, Per Basic Share 3 month | Income (Loss) from Continuing Operations, Per Basic Share 6 month | Income (Loss) from Continuing Operations, Per Basic Share 9 month | Income (Loss) from Continuing Operations, Per Basic Share 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$1.05 10-Q · filed 2026-07-30 | -$1.85 10-Q · filed 2026-07-30 | ||
| 2026-03-31 | -$0.80 10-Q · filed 2026-05-01 | |||
| 2025-12-31 | -$1.97 10-K · filed 2026-02-27 | |||
| 2025-09-30 | -$0.21 10-Q · filed 2025-11-07 | -$1.21 10-Q · filed 2025-11-07 | ||
| 2025-06-30 | -$0.62 10-Q · filed 2026-07-30 | -$0.99 10-Q · filed 2026-07-30 | ||
| 2025-03-31 | -$0.37 10-Q · filed 2026-05-01 | |||
| 2024-12-31 | -$1.41 10-K · filed 2026-02-27 | |||
| 2024-09-30 | -$0.48 10-Q · filed 2025-11-07 | -$1.22 10-Q · filed 2025-11-07 | ||
| 2024-06-30 | -$0.29 10-Q · filed 2025-08-01 | -$0.74 10-Q · filed 2025-08-01 | ||
| 2024-03-31 | -$0.45 10-Q · filed 2025-05-02 | |||
| 2023-12-31 | -$5.63 10-K · filed 2026-02-27 | |||
| 2023-09-30 | -$0.44 10-Q · filed 2024-11-08 | -$1.33 10-Q · filed 2024-11-08 | ||
| 2023-06-30 | -$0.38 10-Q · filed 2024-08-02 | -$0.90 10-Q · filed 2024-08-02 | ||
| 2023-03-31 | -$0.52 10-Q · filed 2024-05-03 | |||
| 2022-12-31 | -$0.80 10-K · filed 2023-02-28 | $4.76 10-K · filed 2025-02-28 | ||
| 2022-09-30 | $0.06 10-Q · filed 2023-11-03 | $5.53 10-Q · filed 2023-11-03 | ||
| 2022-06-30 | $0.38 10-Q · filed 2023-08-04 | $5.46 10-Q · filed 2023-08-04 | ||
| 2022-03-31 | $5.09 10-Q · filed 2023-05-05 | |||
| 2021-12-31 | $3.48 10-K · filed 2023-02-28 | $17.25 10-K · filed 2024-02-28 | ||
| 2021-09-30 | $4.13 10-K · filed 2023-02-28 | $13.79 10-Q · filed 2022-11-07 | ||
| 2021-06-30 | $2.74 10-K · filed 2023-02-28 | $9.68 10-Q · filed 2022-08-04 | ||
| 2021-03-31 | $6.96 10-K · filed 2023-02-28 | |||
| 2020-12-31 | $6.55 10-K · filed 2022-02-28 | $9.44 10-K · filed 2023-02-28 | ||
| 2020-09-30 | $2.11 10-K · filed 2022-02-28 | $2.20 10-Q · filed 2021-11-09 | ||
| 2020-06-30 | $0.15 10-K · filed 2022-02-28 | $0.06 10-Q · filed 2021-08-10 | ||
| 2020-03-31 | -$0.09 10-K · filed 2022-02-28 | |||
| 2019-12-31 | -$0.01 10-K · filed 2021-03-08 | -$0.02 10-K · filed 2022-02-28 | ||
| 2019-09-30 | $0.08 10-K · filed 2021-03-08 | -$0.01 10-Q · filed 2020-11-09 | ||
| 2019-06-30 | $0.02 10-K · filed 2021-03-08 | -$0.09 10-Q · filed 2020-08-05 | ||
| 2019-03-31 | -$0.10 10-K · filed 2021-03-08 | |||
| 2018-12-31 | -$0.11 10-K · filed 2020-03-13 | -$0.31 10-K · filed 2020-03-13 | ||
| 2018-09-30 | -$0.03 10-K · filed 2020-03-13 | -$0.20 10-Q · filed 2019-11-08 | ||
| 2018-06-30 | -$0.06 10-K · filed 2020-03-13 | -$0.17 10-Q · filed 2019-08-12 | ||
| 2018-03-31 | -$0.11 10-K · filed 2020-03-13 | |||
| 2017-12-31 | -$0.14 10-K · filed 2019-03-22 | |||
| 2017-09-30 | -$0.06 10-Q · filed 2018-11-09 | -$0.05 10-Q · filed 2018-11-09 | ||
| 2017-06-30 | $0.00 10-Q · filed 2018-08-13 | $0.01 10-Q · filed 2018-08-13 | ||
| 2017-03-31 | $0.01 10-Q · filed 2018-05-14 | |||
| 2016-09-30 | -$0.44 10-Q · filed 2017-11-13 | -$1.17 10-Q · filed 2017-11-13 | ||
| 2016-06-30 | -$0.66 10-Q · filed 2017-08-14 | -$0.72 10-Q · filed 2017-08-14 | ||
| 2016-03-31 | -$0.05 10-Q · filed 2017-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B |